πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 12 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9114085

Modified release pharmaceutical compositions of dexlansoprazole

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Aug 25 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 20 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8758818

Oral tablet compositions of dexlansoprazole

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Jun 24 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8753682

Dual release oral tablet compositions of dexlansoprazole

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Jun 17 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8741345

Modified release pharmaceutical compositions of dexlansoprazole

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563034

Dual release oral tablet compositions of dexlansoprazole

SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8563035

Oral tablet compositions of dexlansoprazole

Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi Β· Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7678816

Method of stabilizing lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7622588

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7285668

Process for the crystallization of (R)- or (S)-lansoprazole

Takeda Pharmaceutical Company Limited Β· Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7060837

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jun 13 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7022859

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Apr 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6909004

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Tue Jun 21 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired